123 related articles for article (PubMed ID: 22687985)
21. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval.
Drolet B; Khalifa M; Daleau P; Hamelin BA; Turgeon J
Circulation; 1998 Jan; 97(2):204-10. PubMed ID: 9445174
[TBL] [Abstract][Full Text] [Related]
22. Assessment of drug-induced proarrhythmia: The importance of study design in the rabbit left ventricular wedge model.
Lu HR; Gallacher DJ; Yan GX
J Pharmacol Toxicol Methods; 2016; 81():151-60. PubMed ID: 27374776
[TBL] [Abstract][Full Text] [Related]
23. Predictors of torsades de pointes in rabbit ventricles perfused with sedating and nonsedating histamine H1-receptor antagonists.
Gilbert JD; Cahill SA; McCartney DG; Lukas A; Gross GJ
Can J Physiol Pharmacol; 2000 May; 78(5):407-14. PubMed ID: 10841436
[TBL] [Abstract][Full Text] [Related]
24. Arrhythmogenesis in experimental models of heart failure: the role of increased load.
Pye MP; Cobbe SM
Cardiovasc Res; 1996 Aug; 32(2):248-57. PubMed ID: 8796111
[TBL] [Abstract][Full Text] [Related]
25. QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles.
Hamlin RL; Kijtawornrat A; Keene BW; Hamlin DM
Toxicol Sci; 2003 Dec; 76(2):437-42. PubMed ID: 14600288
[TBL] [Abstract][Full Text] [Related]
26. In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits.
Liu XK; Katchman A; Whitfield BH; Wan G; Janowski EM; Woosley RL; Ebert SN
Cardiovasc Res; 2003 Jan; 57(1):28-36. PubMed ID: 12504811
[TBL] [Abstract][Full Text] [Related]
27. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts.
Vermeulen JT; McGuire MA; Opthof T; Coronel R; de Bakker JM; Klöpping C; Janse MJ
Cardiovasc Res; 1994 Oct; 28(10):1547-54. PubMed ID: 8001044
[TBL] [Abstract][Full Text] [Related]
28. G-CSF therapy reduces myocardial repolarization reserve in the presence of increased arteriogenesis, angiogenesis and connexin 43 expression in an experimental model of pacing-induced heart failure.
Milberg P; Klocke R; Frommeyer G; Quang TH; Dieks K; Stypmann J; Osada N; Kuhlmann M; Fehr M; Milting H; Nikol S; Waltenberger J; Breithardt G; Eckardt L
Basic Res Cardiol; 2011 Nov; 106(6):995-1008. PubMed ID: 22072114
[TBL] [Abstract][Full Text] [Related]
29. QT Assessment in Early Drug Development: The Long and the Short of It.
Lester RM; Paglialunga S; Johnson IA
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884748
[TBL] [Abstract][Full Text] [Related]
30. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
Jacobson I; Carlsson L; Duker G
J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model.
Zabel M; Hohnloser SH; Behrens S; Li YG; Woosley RL; Franz MR
J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1148-58. PubMed ID: 9363818
[TBL] [Abstract][Full Text] [Related]
32. Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe.
D'Alonzo AJ; Zhu JL; Darbenzio RB
Eur J Pharmacol; 1999 Mar; 369(1):57-64. PubMed ID: 10204682
[TBL] [Abstract][Full Text] [Related]
33. Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
Ellermann C; Sterneberg M; Kochhäuser S; Dechering DG; Fehr M; Eckardt L; Frommeyer G
Europace; 2018 Oct; 20(10):1699-1706. PubMed ID: 29377987
[TBL] [Abstract][Full Text] [Related]
34. Preclinical strategies to assess QT liability and torsadogenic potential of new drugs: the role of experimental models.
Joshi A; Dimino T; Vohra Y; Cui C; Yan GX
J Electrocardiol; 2004; 37 Suppl():7-14. PubMed ID: 15534787
[TBL] [Abstract][Full Text] [Related]
35. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
Johansson M; Carlsson L
J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
[TBL] [Abstract][Full Text] [Related]
36. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
[TBL] [Abstract][Full Text] [Related]
37. Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs.
Katchman AN; Koerner J; Tosaka T; Woosley RL; Ebert SN
J Pharmacol Exp Ther; 2006 Mar; 316(3):1098-106. PubMed ID: 16278312
[TBL] [Abstract][Full Text] [Related]
38. Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart.
Asano Y; Davidenko JM; Baxter WT; Gray RA; Jalife J
J Am Coll Cardiol; 1997 Mar; 29(4):831-42. PubMed ID: 9091531
[TBL] [Abstract][Full Text] [Related]
39. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
40. Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation.
Lu HR; Remeysen P; De Clerck F
J Cardiovasc Pharmacol; 2000 Dec; 36(6):728-36. PubMed ID: 11117372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
